Citius Pharmaceuticals, Inc. Other Assets
Citius Pharmaceuticals, Inc. (CTXR) had Other Assets of $68.78 million as of 2023-12-31, per its 10-Q filed 2024-02-14.
Discontinued › Balance Sheet › Assets
us-gaap:OtherAssets · last filed 2024-02-14
- 2023-12-31: Other Assets $68.78M.
- 2023-09-30: Other Assets $68.78M.
- 2023-06-30: Other Assets $68.78M.
- 2023-03-31: Other Assets $68.78M.
| Period end | Other Assets | Other Assets as first filed |
|---|---|---|
| 2023-12-31 | $68.78M 10-Q · filed 2024-02-14 | |
| 2023-09-30 | $68.78M 10-Q · filed 2024-02-14 | |
| 2023-06-30 | $68.78M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $68.78M 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $68.78M 10-Q · filed 2023-02-10 | |
| 2022-09-30 | $68.78M 10-K · filed 2023-12-29 | |
| 2022-06-30 | $68.78M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $68.78M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $68.78M 10-Q · filed 2022-02-10 | |
| 2021-09-30 | $68.78M 10-K · filed 2022-12-22 | |
| 2021-06-30 | $28.78M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $28.78M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $28.78M 10-Q · filed 2021-02-11 | |
| 2020-09-30 | $28.80M 10-K · filed 2021-12-15 | |
| 2020-06-30 | $28.80M 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $21.04M 10-Q · filed 2020-05-14 | |
| 2019-12-31 | $21.04M 10-Q · filed 2020-02-13 | |
| 2019-09-30 | $28.80M 10-K · filed 2020-12-16 | $21.04M 10-K · filed 2019-12-16 |
| 2019-06-30 | $20.99M 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $20.99M 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $20.99M 10-Q · filed 2019-02-14 | |
| 2018-09-30 | $20.99M 10-K · filed 2019-12-16 | |
| 2018-06-30 | $20.99M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $20.99M 10-Q · filed 2018-05-11 | |
| 2017-12-31 | $20.99M 10-Q · filed 2018-02-14 | |
| 2017-09-30 | $20.99M 10-K · filed 2018-12-11 | |
| 2017-06-30 | $21.01M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $20.99M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $20.99M 10-Q · filed 2017-02-14 | |
| 2016-09-30 | $21.05M 10-K · filed 2017-12-13 | |
| 2016-06-30 | $20.99M 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $20.99M 10-Q · filed 2016-05-20 | |
| 2015-09-30 | $5.40K 10-K · filed 2016-12-23 | |
| 2014-09-30 | $5.40K 10-K · filed 2015-12-14 | |
| 2013-12-31 | $5.40K 10-KT · filed 2014-12-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |